Latest News

June 2009 - Auxocell Laboratories, Inc. has entered into a licensing agreement with Community Blood Services and the New Jersey Cord Blood Bank. This license will allow Community Blood Services to operate the first Wharton's Jelly/Cord Tissue derived stem cell bank in the United States. For more information please click here.

June 2008 - AuxoCell Laboratories, Inc. is excited to announce the hiring of Rouzbeh Taghizadeh as Chief Scientific Officer. Dr. Taghizadeh completed his Ph.D., in stem cell biology from the Massachusetts Institute of Technology. He has extensive knowledge and expertise in adult stem cells, especially human hematopoietic stem cells – the regenerative cells involved in bone marrow and umbilical cord blood transplantations. For Dr. Taghizadeh’s full Bio please click here.